Trial Profile
A prospective, single-blind, follow-up study to assess the efficacy and long-term safety of high-dose dimethyl fumarate in patients with moderate to severe psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- 22 Oct 2016 New trial record